1152P Association of immune-related adverse events (irAE) requiring glucocorticoids (GCs) with outcome and biomarkers in advanced cutaneous malignant melanoma (CMM) treated with immune checkpoint inhibitors (ICI).
Saved in:
| Title: | 1152P Association of immune-related adverse events (irAE) requiring glucocorticoids (GCs) with outcome and biomarkers in advanced cutaneous malignant melanoma (CMM) treated with immune checkpoint inhibitors (ICI). |
|---|---|
| Authors: | Costa Svedman, F.1 (AUTHOR), Liapi, M.2 (AUTHOR), Chatzidionysiou, A.2 (AUTHOR), Månsson-Broberg, A.3 (AUTHOR), Egyhazi Brage, S.4 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS688-S689. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173099057 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1152P Association of immune-related adverse events (irAE) requiring glucocorticoids (GCs) with outcome and biomarkers in advanced cutaneous malignant melanoma (CMM) treated with immune checkpoint inhibitors (ICI). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Costa+Svedman%2C+F%2E%22">Costa Svedman, F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liapi%2C+M%2E%22">Liapi, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chatzidionysiou%2C+A%2E%22">Chatzidionysiou, A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Månsson-Broberg%2C+A%2E%22">Månsson-Broberg, A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Egyhazi+Brage%2C+S%2E%22">Egyhazi Brage, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS688-S689. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173099057 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.09.2286 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S688 Titles: – TitleFull: 1152P Association of immune-related adverse events (irAE) requiring glucocorticoids (GCs) with outcome and biomarkers in advanced cutaneous malignant melanoma (CMM) treated with immune checkpoint inhibitors (ICI). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Costa Svedman, F. – PersonEntity: Name: NameFull: Liapi, M. – PersonEntity: Name: NameFull: Chatzidionysiou, A. – PersonEntity: Name: NameFull: Månsson-Broberg, A. – PersonEntity: Name: NameFull: Egyhazi Brage, S. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2023 Supplement 2 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |